Annual Operating Profit
-$38.08 M
-$9.16 M-31.67%
31 December 2023
Summary:
SAB Biotherapeutics annual operaing income is currently -$38.08 million, with the most recent change of -$9.16 million (-31.67%) on 31 December 2023. During the last 3 years, it has fallen by -$58.63 million (-285.22%). SABS annual operating profit is now -285.22% below its all-time high of $20.56 million, reached on 31 December 2020.SABS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$11.31 M
-$1.11 M-10.86%
30 September 2024
Summary:
SAB Biotherapeutics quarterly operating income is currently -$11.31 million, with the most recent change of -$1.11 million (-10.86%) on 30 September 2024. Over the past year, it has dropped by -$5.99 million (-112.47%). SABS quarterly operating profit is now -321.94% below its all-time high of $5.10 million, reached on 31 March 2022.SABS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$51.78 M
-$5.99 M-13.07%
30 September 2024
Summary:
SAB Biotherapeutics TTM operating income is currently -$51.78 million, with the most recent change of -$5.99 million (-13.07%) on 30 September 2024. Over the past year, it has dropped by -$24.71 million (-91.33%). SABS TTM operating profit is now -6461.41% below its all-time high of $813.90 thousand, reached on 31 March 2021.SABS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.7% | -112.5% | -91.3% |
| 3 y3 years | -285.2% | -183.4% | -755.9% |
| 5 y5 years | - | - | - |
SABS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -285.2% | at low | -321.9% | +40.1% | -755.9% | at low |
| 5 y | 5 years | -285.2% | at low | -321.9% | +40.1% | -6461.4% | at low |
| alltime | all time | -285.2% | at low | -321.9% | +40.1% | -6461.4% | at low |
SAB Biotherapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.31 M(+10.9%) | -$51.78 M(+13.1%) |
| June 2024 | - | -$10.20 M(-10.4%) | -$45.79 M(+8.9%) |
| Mar 2024 | - | -$11.39 M(-39.6%) | -$42.06 M(+10.5%) |
| Dec 2023 | -$38.08 M(+31.7%) | -$18.87 M(+254.6%) | -$38.08 M(+40.7%) |
| Sept 2023 | - | -$5.32 M(-17.8%) | -$27.06 M(-8.4%) |
| June 2023 | - | -$6.48 M(-12.5%) | -$29.55 M(-0.2%) |
| Mar 2023 | - | -$7.40 M(-5.8%) | -$29.61 M(+73.0%) |
| Dec 2022 | -$28.92 M | -$7.86 M(+0.7%) | -$17.11 M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$7.81 M(+19.3%) | -$16.60 M(+29.9%) |
| June 2022 | - | -$6.54 M(-228.4%) | -$12.78 M(+40.3%) |
| Mar 2022 | - | $5.10 M(-169.4%) | -$9.11 M(-32.0%) |
| Dec 2021 | -$13.39 M(-165.2%) | -$7.34 M(+84.0%) | -$13.39 M(+121.4%) |
| Sept 2021 | - | -$3.99 M(+38.9%) | -$6.05 M(+193.8%) |
| June 2021 | - | -$2.87 M(-452.9%) | -$2.06 M(-352.9%) |
| Mar 2021 | - | $813.90 K | $813.90 K |
| Dec 2020 | $20.56 M(-337.0%) | - | - |
| Dec 2019 | -$8.67 M | - | - |
FAQ
- What is SAB Biotherapeutics annual operaing income?
- What is the all time high annual operating profit for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual operating profit year-on-year change?
- What is SAB Biotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly operating profit year-on-year change?
- What is SAB Biotherapeutics TTM operating income?
- What is the all time high TTM operating profit for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM operating profit year-on-year change?
What is SAB Biotherapeutics annual operaing income?
The current annual operating profit of SABS is -$38.08 M
What is the all time high annual operating profit for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual operaing income is $20.56 M
What is SAB Biotherapeutics annual operating profit year-on-year change?
Over the past year, SABS annual operaing income has changed by -$9.16 M (-31.67%)
What is SAB Biotherapeutics quarterly operating income?
The current quarterly operating profit of SABS is -$11.31 M
What is the all time high quarterly operating profit for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly operating income is $5.10 M
What is SAB Biotherapeutics quarterly operating profit year-on-year change?
Over the past year, SABS quarterly operating income has changed by -$5.99 M (-112.47%)
What is SAB Biotherapeutics TTM operating income?
The current TTM operating profit of SABS is -$51.78 M
What is the all time high TTM operating profit for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM operating income is $813.90 K
What is SAB Biotherapeutics TTM operating profit year-on-year change?
Over the past year, SABS TTM operating income has changed by -$24.71 M (-91.33%)